1416. Thymoquinone inhibits phorbol ester-induced activation of NF-κB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo.
Kundu JK1, Liu L, Shin JW, Surh YJ.
Biochem Biophys Res Commun. 2013 Sep 6;438(4):721-7. doi: 10.1016/j.bbrc.2013.07.110. Epub 2013 Aug 1.Link
1415. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1.
1414. Hybrid scaffold composed of hydrogel/3D-framework and its application as a dopamine delivery system
Kang KS1, Lee SI2, Hong JM1, Lee JW1, Cho HY3, Son JH4, Paek SH5, Cho DW6.
J Control Release. 2014 Feb 10;175:10-6. doi: 10.1016/j.jconrel.2013.12.002. Epub 2013 Dec 12.Link
1413. Application of the multiplex cytokine analysis to monitor xenogeneic immune responses to the porcine islet graft in non-human primate.
Kim YH1, Kim JS, Yoon IH, Shin JS, Kim JM, Kim SJ, Park CG.
J Korean Med Sci. 2013 Dec;28(12):1729-33. doi: 10.3346/jkms.2013.28.12.1729. Epub 2013 Nov 26.Link
1412. Role of regulatory T cells in transferable immunological tolerance to bone marrow donor in murine mixed chimerism model.
Yoon IH1, Kim YH, Kim YS, Shin JS, Park CG.
J Korean Med Sci. 2013 Dec;28(12):1723-8. doi: 10.3346/jkms.2013.28.12.1723. Epub 2013 Nov 26.Link
1411. Korean risk assessment model for breast cancer risk prediction.
Park B1, Ma SH, Shin A, Chang MC, Choi JY, Kim S, Han W, Noh DY, Ahn SH, Kang D, Yoo KY, Park SK.
PLoS One. 2013 Oct 25;8(10):e76736. doi: 10.1371/journal.pone.0076736. eCollection 2013.Link
1410. Dietary intake and breast cancer among carriers and noncarriers of BRCA mutations in the Korean Hereditary Breast Cancer Study.
Ko KP1, Kim SW, Ma SH, Park B, Ahn Y, Lee JW, Lee MH, Kang E, Kim LS, Jung Y, Cho YU, Lee B, Lin JH, Park SK.
Am J Clin Nutr. 2013 Dec;98(6):1493-501. doi: 10.3945/ajcn.112.057760. Epub 2013 Oct 23.Link
1409. Soluble c-Met protein as a susceptible biomarker for gastric cancer risk: A nested case-control study within the Korean Multicenter Cancer Cohort.
Yang JJ1, Yang JH, Kim J, Ma SH, Cho LY, Ko KP, Shin A, Choi BY, Kim HJ, Han DS, Eun CS, Song KS, Kim YS, Chang SH, Shin HR, Kang D, Yoo KY, Park SK
Int J Cancer. 2013 May 1;132(9):2148-56. doi: 10.1002/ijc.27861. Epub 2012 Oct 25.Link
1408. Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
Shin HC1, Han W, Moon HG, Im SA, Moon WK, Park IA, Park SJ, Noh DY.
Ann Surg Oncol. 2013 Aug;20(8):2582-9. doi: 10.1245/s10434-013-2909-6. Epub 2013 Mar 16.Link